Evidence map›Paper›PMID 40372562›Full record

ArticleCerebellum (London, England)2025

Alterations in the Na

Louis-Charles Masson, Atchaya S Kanagasabai, Brenda Toscano Márquez, Julia Tourbina-Kolomiets, Francois Charron, Alanna J Watt, R Anne McKinney

Abstract read
In one paragraph

Article in Cerebellum (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The Recycling Endosomal (NaActa physiologica (Oxford, England) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Louis-Charles Masson *Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.
Atchaya S Kanagasabai *Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.
Brenda Toscano MárquezDepartment of Biology, McGill University, Montreal, QC, Canada.
Julia Tourbina-KolomietsDepartment of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.
Francois CharronDepartment of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.
Alanna J WattDepartment of Biology, McGill University, Montreal, QC, Canada. alanna.watt@mcgill.ca.
R Anne McKinneyDepartment of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada. anne.mckinney@mcgill.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patterned cell death is a common feature of many neurodegenerative diseases. This is apparent in cerebellar Purkinje cells (PCs) in patients and mouse models of Autosomal-recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). In ARSACS, PCs in the anterior cerebellar vermis are vulnerable to degeneration while those in the posterior vermis are resilient. As the mechanisms underpinning cerebellar pathophysiology in ARSACS are not fully understood, we chose to investigate two important regulatory pathways for cellular health in neurons: (1) the autophagy-lysosome pathway which is important for the trafficking of cargo essential for proper neuronal function, as well as (2) excitatory amino acid transporters (EAATs) that regulate extracellular glutamate levels. Using a mouse model of ARSACS (Sacs

Indexed as

Amino Acid Transport System X-AGGlutamate Plasma Membrane Transport ProteinsPurkinje CellsSodium-Hydrogen ExchangersSpinocerebellar AtaxiasAnimalsCerebellumDisease Models, AnimalMiceMice, Inbred C57BLMice, KnockoutAmino Acid Transport System X-AGGlutamate Plasma Membrane Transport ProteinsNHE6 protein, mouseSodium-Hydrogen ExchangersAtaxiaEndosomesGlutamate transporterspHPurkinje cells

Identifiers

PMID40372562
PMCPMC12081547

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.